About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers.  To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu  and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.

About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers. To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.

Breakthrough Therapies- HER2 with Dr. Bob T. Li

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Science

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Share Breakthrough Therapies- HER2 with Dr. Bob T. Li

Sign up to save your podcasts

Breakthrough Therapies- HER2 with Dr. Bob T. Li

Breakthrough Therapies- HER2 with Dr. Bob T. Li

More shows like Lung Cancer Considered

Freakonomics Radio

NEJM This Week

JAMA Clinical Reviews

Hidden Brain

The NPR Politics Podcast

ASCO Daily News

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The Peter Attia Drive

Harrison's PodClass: Internal Medicine Cases and Board Prep

The Curious Clinicians

People I (Mostly) Admire

Conversations in Lung Cancer Research

The Weekly Show with Jon Stewart

Two Onc Docs